31 Leading Digital PCR Companies Shaping Innovation and Market Growth
Discover the top 31 companies transforming the digital PCR and qPCR market, including Danaher Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., and other industry leaders. Backed by a market projected to grow from $10.0B to $14.8B by 2029 at a CAGR of 8.1%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the future of the industry....
25 Leading Flow Cytometry Companies Shaping Innovation and Market Growth
Discover the top 25 companies transforming the flow cytometry market, including Becton, Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific Inc., and other industry leaders. Backed by a market projected to grow from $5.06B to $9.85B by 2033 at a CAGR of 8.7%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the future of the industry....
33 Leading Single-use Bioreactors Companies Shaping Innovation and Market Growth
Discover the top 33 companies transforming the single-use bioreactors market, including Sartorius AG, Danaher Corporation, Thermo Fisher Scientific Inc., and other industry leaders. Backed by a market projected to grow from $4.4B to $9.1B by 2029 at a CAGR of 15.4%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the future of the industry. Access...
26 Leading Antibody Drug Conjugates Companies Shaping Innovation and Market Growth
Discover the top 26 companies transforming the antibody drug conjugates market, including F. Hoffmann-La Roche Ltd., Daiichi Sankyo Company, Limited, Seagen Inc., and other industry leaders. Backed by a market projected to grow from $9.7B to $19.8B by 2028 at a CAGR of 15.2%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the future of the industry....
Genomics Market by Region: A Global Growth Story
The genomics market is projected to reach USD 85.09 billion by 2030 from USD 47.07 billion in 2025, registering a CAGR of 12.6% from 2025 to 2030. The growth of the genomics market is driven by increasing government funding for genomics projects, a rising prevalence of viral and inherited disorders, advancements in NGS platforms, and the expansion of applications in genomics.
The...
28 Leading Genomics Companies Shaping Innovation and Market Growth
Discover the top 28 companies transforming the genomics market, including Thermo Fisher Scientific Inc., Illumina, Inc., Danaher Corporation, and other industry leaders. Backed by a market projected to grow from $47.07B to $85.09B by 2030 at a CAGR of 12.6%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the future of the industry. Access the...
28 Leading Single Use Assemblies Companies Shaping Innovation and Market Growth
Discover the top 28 companies transforming the single-use assemblies market, including Thermo Fisher Scientific Inc., Sartorius AG, Merck KGaA, and other industry leaders. Backed by a market projected to grow from US$2.63B to US$4.89B by 2029 at a CAGR of 13.2%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the future of the industry. Access...
30 Leading Next Generation Sequencing Companies Shaping Innovation and Market Growth
Discover the top 30 companies transforming the next-generation sequencing market, including Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., and other industry leaders. Backed by a market projected to grow from $13.81 billion to $27.14 billion by 2031 at a CAGR of 14.5%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping...
Genomic Biomarkers Market to Reach $50.31 Billion by 2030
According to recent market analysis, the Genomic Biomarkers Market is projected to grow from USD 29.00 billion in 2025 to USD 50.31 billion by 2030, registering a robust CAGR of 11.6% during the forecast period. This growth reflects the increasing reliance on genomic insights to enhance clinical decision-making and therapeutic outcomes. The global genomic biomarkers market is witnessing...
Stem Cell Assays Market Size and Growth Forecast North America (US, Canada), Europe (Germany, France, UK, Italy, Spain, Netherlands), Asia Pacific (Japan, China, India, Australia), Latin America (Brazil, Mexico, Argentina)
The global stem cell assays market was valued at USD 1.9 billion in 2022 and is projected to reach USD 4.5 billion by 2027. This expansion represents a compound annual growth rate (CAGR) of 17.7% during the forecast period from 2022 to 2027. The market’s growth is primarily fueled by increasing awareness of the therapeutic potency of stem cells, rising demand for cell-based assays in drug discovery,...